PAUL HOPKINS to Cholesterol, LDL
This is a "connection" page, showing publications PAUL HOPKINS has written about Cholesterol, LDL.
Connection Strength
1.018
-
A comparative study of four independent methods to measure LDL particle concentration. Atherosclerosis. 2015 Nov; 243(1):99-106.
Score: 0.366
-
Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations. J Clin Lipidol. 2019 Nov - Dec; 13(6):970-978.
Score: 0.122
-
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S9-17.
Score: 0.067
-
Evaluation of the gene-age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent. Atherosclerosis. 2011 Jul; 217(1):139-41.
Score: 0.067
-
Defining the challenges of familial hypercholesterolemia screening: introduction. J Clin Lipidol. 2010 Sep-Oct; 4(5):342-5.
Score: 0.065
-
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study. Atherosclerosis. 2009 Dec; 207(2):559-66.
Score: 0.059
-
Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005 Sep; 117(5):444-51.
Score: 0.045
-
Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2001 Mar 01; 87(5):547-53.
Score: 0.034
-
Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia. J Clin Lipidol. 2018 Mar - Apr; 12(2):390-396.e8.
Score: 0.027
-
The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred. J Clin Lipidol. 2018 Jan - Feb; 12(1):152-161.
Score: 0.027
-
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994 Apr; 40(4):552-61.
Score: 0.021
-
Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One. 2012; 7(10):e48663.
Score: 0.019
-
Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction. Arterioscler Thromb. 1991 Sep-Oct; 11(5):1137-46.
Score: 0.017
-
Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status. Atherosclerosis. 2011 Apr; 215(2):435-9.
Score: 0.017
-
Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations. J Hum Genet. 2008; 53(3):193-200.
Score: 0.013
-
Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005 Sep; 116(3):682-8.
Score: 0.011
-
Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol. 2001 Dec; 21(12):1969-76.
Score: 0.009
-
Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res. 2000 Sep; 41(9):1428-36.
Score: 0.008
-
Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res. 1997 Jul; 38(7):1361-73.
Score: 0.006
-
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens. 1993 Nov; 6(11 Pt 2):319S-327S.
Score: 0.005
-
Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes. Arterioscler Thromb. 1991 Sep-Oct; 11(5):1349-55.
Score: 0.004
-
Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989 May-Jun; 9(3):335-44.
Score: 0.004
-
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988 Jun 24; 259(24):3579-86.
Score: 0.003